MHRA-102483-PIP01-26

Key Facts

Active Substance
Active Substance:
  • Efimosfermin alfa
Invented Name
Not yet available
PIP Number MHRA-102483-PIP01-26
Pharmaceutical form(s)
  • All pharmaceutical forms
  • All pharmaceutical forms
Therapeutic area
Therapeutic area:
  • Gastroenterology-Hepatology
Conditions / Indications
Conditions / Indications:
  • Treatment of alcohol-related liver disease
Route(s) of administration
Route(s) of administration:
  • All routes of administration
PIP applicant
Decision Type
Decision Type
W: decision granting a waiver in all age groups for the listed condition(s).
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Efimosfermin alfa.pdf
Published Date 14/10/2026